| 000 | 01341 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516173851.0 | ||
| 264 | 0 | _c20140404 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1744-8387 | ||
| 024 | 7 |
_a10.1586/14789450.2013.840440 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Alessandro, Angelo | |
| 245 | 0 | 0 |
_aProteomics and metabolomics in cancer drug development. _h[electronic resource] |
| 260 |
_bExpert review of proteomics _cOct 2013 |
||
| 300 |
_a473-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aAutophagy |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolome |
| 650 | 0 | 4 |
_aNeoplasms _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPeptide Fragments _xgenetics |
| 650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
| 650 | 0 | 4 |
_aProteome _xanalysis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aZolla, Lello | |
| 773 | 0 |
_tExpert review of proteomics _gvol. 10 _gno. 5 _gp. 473-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14789450.2013.840440 _zAvailable from publisher's website |
| 999 |
_c23163016 _d23163016 |
||